Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series

In Japan, drug therapy for schizophrenia is characterized by high-dose antipsychotic polypharmacy, which is an uncommon approach internationally. In this study, we reduced the number of antipsychotic agents in 5 patients using the Safety Correction of High-dose Antipsychotic Polypharmacy (SCAP) meth...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Psychopharmacol Neurosci
Главные авторы: Kamei, Hiroyuki, Yamada, Hanae, Hatano, Masakazu, Hanya, Manako, Yamada, Shigeki, Iwata, Nakao
Формат: Artigo
Язык:Inglês
Опубликовано: Korean College of Neuropsychopharmacology 2020
Предметы:
Case Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7006980/
https://ncbi.nlm.nih.gov/pubmed/31958917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2020.18.1.159
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы